Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients

Inflammatory Bowel Diseases

Volumn 16, Issue 8, 2010, Pages 1311-1321

  Kosovac, Katrin ^a   Brenmoehl, Julia ^b   Holler, Ernst ^a   Falk, Werner ^a   Schoelmerich, Juergen ^a   Hausmann, Martin ^c   Rogler, Gerhard ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bacterial translocation; Crohn's disease; Endotoxin; NF B; NOD2; SNPs

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MURAMYL DIPEPTIDE;

ARTICLE; BACTERIAL TRANSLOCATION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME ACTIVATION; EPITHELIUM CELL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; LAMINA PROPRIA; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; BACTERIAL TRANSLOCATION; BETA CATENIN; CADHERINS; CLAUDINS; CROHN DISEASE; ENDOTOXINS; HUMANS; INTERCELLULAR JUNCTIONS; INTERLEUKIN-8; MEMBRANE PROTEINS; MUCOUS MEMBRANE; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 77949471940     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21223     Document Type: Article

References (53)

1. Carneiro LA, Magalhaes JG, Tattoli I, et al. Nod-like proteins in inflammation and disease. J Pathol. 2008;214:136-148.
2. Kumagai Y, Takeuchi O, Akira S. Pathogen recognition by innate receptors. J Infect Chemother. 2008;14:86-92.
3. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
4. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606. (Pubitemid 32531409)
5. Li X, Stark GR. NFkappaB-dependent signaling pathways. Exp Hematol. 2002;30:285-296.
6. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999;18:6853-6866.
7. Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557-561. (Pubitemid 46514732)
8. Fritz JH, Ferrero RL, Philpott DJ, et al. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006;7:1250-1257.
9. Hugot JP. CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci. 2006;1072:9-18.
10. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371-382. (Pubitemid 37323197)
11. Li J, Moran T, Swanson E, et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet. 2004;13:1715-1725. (Pubitemid 39173441)
12. Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science. 2005;307:734-738. (Pubitemid 40194645)
13. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-1640. (Pubitemid 46722636)
14. Hollander D. Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep. 1999;1:410-416.
15. Hollander D. Intestinal permeability in patients with Crohn's disease and their relatives. Dig Liver Dis. 2001;33:649-651. (Pubitemid 33107661)
16. Saitou M, Fujimoto K, Doi Y, et al. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol. 1998;141:397-408. (Pubitemid 28237088)
17. Balda MS, Whitney JA, Flores C, et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996;134:1031-1049. (Pubitemid 26278226)
18. Bamforth SD, Kniesel U, Wolburg H, et al. A dominant mutant of occludin disrupts tight junction structure and function. J Cell Sci. 1999;112:1879-1888. (Pubitemid 29338813)
19. McCarthy KM, Skare IB, Stankewich MC, et al. Occludin is a functional component of the tight junction. J Cell Sci. 1996;109:2287-2298. (Pubitemid 26325491)
20. Amasheh S, Meiri N, Gitter AH, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci. 2002;115:4969-4976. (Pubitemid 36061180)
21. Furuse M, Hata M, Furuse K, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol. 2002;156:1099-1111. (Pubitemid 34839858)
22. Van Itallie C, Rahner C, Anderson JM. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest. 2001;107:1319-1327. (Pubitemid 32494549)
23. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, et al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem. 2000;275:27979-27988.
24. Fanning AS, Jameson BJ, Jesaitis LA, et al. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998;273:29745-29753.
25. Itoh M, Furuse M, Morita K, et al. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 1999;147:1351-1363. (Pubitemid 30012818)
26. Itoh M, Nagafuchi A, Moroi S, et al. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol. 1997;138:181-92. (Pubitemid 27337462)
27. Schmidt A, Utepbergenov DI, Krause G, et al. Use of surface plasmon resonance for real-time analysis of the interaction of ZO-1 and occludin. Biochem Biophys Res Commun. 2001;288:1194-1199. (Pubitemid 33131727)
28. Wittchen ES, Haskins J, Stevenson BR. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem. 1999;274:35179-35185. (Pubitemid 129509574)
29. Aberle H, Schwartz H, Kemler R. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem. 1996;61:514-523. (Pubitemid 26240128)
30. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996;84:345-357.
31. Menzel K, Hausmann M, Obermeier F, et al. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol. 2006;146:169-180. (Pubitemid 44393851)
32. Hofmann C, Obermeier F, Artinger M, et al. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology. 2007;132:587-600. (Pubitemid 46274657)
33. Rogler G, Hausmann M, Vogl D, et al. Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol. 1998;112:205-215. (Pubitemid 28266678)
34. DeMeo MT, Mutlu EA, Keshavarzian A, et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34:385-396.
35. Wiest R, Rath HC. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol. 2003;17:397-425.
36. Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl. 2001:29-40.
37. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol. 2002;97:939-946. (Pubitemid 34408252)
38. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620-1633.
39. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837-848.
40. Mylonaki M, Rayment NB, Rampton DS, et al. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:481-487. (Pubitemid 40704083)
41. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37:1034-1041.
42. Schultsz C, Van Den Berg FM, Ten Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999;117:1089-1097. (Pubitemid 29512667)
43. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A. 2005;102:18129-18134. (Pubitemid 41798513)
44. Shirazi T, Longman RJ, Corfield AP, et al. Mucins and inflammatory bowel disease. Postgrad Med J. 2000;76:473-478.
45. Schreiber S, Nikolaus S, Hampe J, et al. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet. 1999;353:459-461. (Pubitemid 29067338)
46. Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci. 2006;1072:242-252. (Pubitemid 44448457)
47. Dhawan P, Singh AB, Deane NG, et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115:1765-1776. (Pubitemid 40979715)
48. Burgel N, Bojarski C, Mankertz J, et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology. 2002;123:433-443.
49. Ichiyasu H, McCormack JM, McCarthy KM, et al. Matrix metalloproteinase- 9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am J Respir Cell Mol Biol. 2004;30:761-770. (Pubitemid 38744524)
50. Miyamori H, Takino T, Kobayashi Y, et al. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem. 2001;276:28204-28211. (Pubitemid 37391525)
51. Balda MS, Matter K. Transmembrane proteins of tight junctions. Semin Cell Dev Biol. 2000;11:281-289.
52. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68:7010-7017. (Pubitemid 32463415)
53. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol. 2005;174:4453-4460. (Pubitemid 40504521)